effect of subcutaneus epinephrine on hemodynamic changes and bleeding in rhinoplasty.
Conditions
Interventions
Intervention 1: Intervention group: solution of subcutaneus epinephrine 1/200000 with lidocaine 2%. Intervention 2: Control group: subcutaneus epinephrine 1/100000 with lidocaine 2%.
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
16 Years to 45 Years
Inclusion criteria
Inclusion criteria: People aged 16-45 years ASA I,II
Exclusion criteria
Exclusion criteria: Coagulation disorder Heart disease hypertension Cerebrovascular disease Renal disease drug Allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Systolic and diastolic and mean arterial pressure. Timepoint: Before inductin by anesthesia, after intubation and then at intervals before anesthesia, after intubation, immediately before epinephrine injection, and then every minute to the third minutes after injection, and then every 5 minutes until the end of the procedure. Method of measurement: Non-invasive automatic measurement by a monitoring device.;Heart rate. Timepoint: Before inductin by anesthesia, after intubation and then at intervals before anesthesia, after intubation, immediately before epinephrine injection, and then every minute to the third minutes, and then every 5 minutes until the end of the procedure. Method of measurement: EKG monitoring.;Rate of bleeding. Timepoint: End of surgury. Method of measurement: Measurment of blood in bottle of suction and number of bloody gases. | — |
Secondary
| Measure | Time frame |
|---|---|
| Volume of infused propofol. Timepoint: End of surgery. Method of measurement: Volume of infusion in milliliter.;Volume of infused remifentanil. Timepoint: End of surgery. Method of measurement: Volume of infusion in milliliter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohadeseh Ahmadi
Kerman University of Medical Sciences
Outcome results
None listed